Antibody glycosylation in neuroimmune diseases. [PDF]
Li K +10 more
europepmc +1 more source
Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring. [PDF]
Monteiro JF +7 more
europepmc +1 more source
Obstetric Pharmacology at an Inflection Point. [PDF]
Eke AC.
europepmc +1 more source
Case Report: KLHL11 encephalitis in a female patient with dual primary malignancies of breast and lung cancer: response to FcRn inhibitor therapy. [PDF]
Li Y, Xing H, Cao Z, Cui P, Zhao L.
europepmc +1 more source
Nipocalimab in the management of generalized myasthenia gravis: a new targeted therapeutic approach. [PDF]
Khalid M, Haider E, Khan A, Haider NU.
europepmc +1 more source
The FcRn from gene to protein and function: comparison between species. [PDF]
Ortiz-Alegría LB +4 more
europepmc +1 more source
Glycoengineering of plant-produced Pembrolizumab enhances FcRn binding and extends serum half-life in mice. [PDF]
Bulaon CJI +9 more
europepmc +1 more source
Selective decoupling of IgG1 binding to viral Fc receptors restores antibody-mediated NK cell activation against HCMV. [PDF]
Qerqez AN +19 more
europepmc +1 more source
Expanding Evidence of Leptomeningeal Involvement in MOGAD and Its Relevance to Its Pathophysiology. [PDF]
Cacciaguerra L, Flanagan EP.
europepmc +1 more source

